Who founded Chameleon Biosciences?

Chameleon Biosciences was founded by Genine Winslow in 2017.

Who are Chameleon Biosciences's investors?

Chameleon Biosciences's investors include Berkeley SkyDeck Fund, Future Planet Capital, Solasta Ventures, Tachyon Ventures.

How much funding has Chameleon Biosciences raised?

Chameleon Biosciences has disclosed $10.6M raised across 1 round.

Where is Chameleon Biosciences headquartered?

Chameleon Biosciences is headquartered in Berkeley, US.

Chameleon Biosciences

Berkeley, US · Founded 2017 · Delaware corporation · 4 known investors

Find your way into Chameleon Biosciences

1,238 people in our graph share verified history with the Chameleon Biosciences team — schools, employers, funds. One of them is your warm intro.

Scott Davisunlockedknows Genine Winslow · together at University of California, Berkeley (overlapped)

×11knows the team · via University of California, Berkeley

Biotech

Founders & leadership

Chameleon Biosciences was founded in 2017 by Genine Winslow.

Genine Winslow inFounderGenine Winslow was previously CEO of Editpep, a company developing CRISPR-based peptide delivery to the central nervous system, and has advised early-stage cell and gene therapy programs through G Winslow Consulting, drawing on expertise in immunology and genetic medicine drug development.

Ran GengNamed on SEC filing

Winnie WanNamed on SEC filing

Investors · 4

Berkeley SkyDeck FundBerkeley · $200K

Future Planet CapitalLondon

Solasta VenturesBoston

Tachyon VenturesLos Angeles

Reported raises · per SEC filings

Form D private placements

$10.6M disclosed across 1 round · 2021

▶$10.6MraisedMar 2021 · 23 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ran GengDirector
Winnie WanDirector
Genine A. WinslowExecutive Officer, Director

Offering amount: $23M
Amount sold: $10.6M
First sale: Mar 2021
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CureDuchenne Invests in Chameleon Biosciences to Support EVADERTM, a Next Generation Adeno Associated Virus Based Gene Therapy Platform Technology - CureDuchennecureduchenne.org · Sep 2019

Frequently asked questions

Who founded Chameleon Biosciences?: Chameleon Biosciences was founded by Genine Winslow in 2017.
Who are Chameleon Biosciences's investors?: Chameleon Biosciences's investors include Berkeley SkyDeck Fund, Future Planet Capital, Solasta Ventures, Tachyon Ventures.
How much funding has Chameleon Biosciences raised?: Chameleon Biosciences has disclosed $10.6M raised across 1 round.
Where is Chameleon Biosciences headquartered?: Chameleon Biosciences is headquartered in Berkeley, US.